Autumn InterAction Meeting Program

I summarise below the list of sessions with over 100 top speakers and discussion leaders for the program listing for the upcoming Autumn InterAction Meetings taking place in Philadelphia and Basel. Please add a traceback or link for other like-minded folk to find!

I also provide an electronic brochure for download here for the InnovationWell Autumn Program on Knowledge-based Innovation in Life Science Product Development:
http://barryhardy.blogs.com/theferryman/files/InnovationWell-ProgramAutumn05.PDF

And the equivalent eCheminfo brochure on Drug Discovery:
http://barryhardy.blogs.com/theferryman/files/eCheminfo-ProgramAutumn05.pdf

Note: The poster sessions will be run as electronic poster sessions using tabletop spaces, a wireless network and Internet facilities at the meetings, in addition to virtual access through the website, i.e., the posters will be electronic but the access can be face-to-face or virtual. You can participate in person and virtually in the poster sessions.  We can supply nourishment and refreshments locally; remote participants may have to order out! [We also expect, subject to on-site testing, to have live conference call capabilities for remote participating members to join local discussions.]  Anyone interested in presenting such an "electronic poster" should directly contact us via email at innovationwell at douglasconnect.com

Look forward to seeing you in Philadelphia or Basel!

Barry Hardy
Community of Practice Manager
Douglas Connect
http://douglasconnect.com/
+41 61 851 0170 (office)

InnovationWell & eCheminfo InterAction Meetings
Philadelphia, US, 11-12 October 2005 and Basel, Switzerland, 9-10 November
List of Sessions with Speakers & Schedule (InterAction Autumn Meetings)
http://innovationwell.net/ and http://echeminfo.com/

Registration to attend the meetings or to access virtually is available through the websites or through contacting Nicki Douglas [nicki.douglas at douglasconnect.com]

InnovationWell eCheminfo meeting workshop conference management executive drug safety KM Life Sciences Pharma Drug Discovery Drug Development Healthcare Innovation Informatics cheminformatics Knowledge Management events

…PROGRAM LISTING CONTINUING IN FULL POSTING…..

Philadelphia, US, 11-12 October

11 October, Morning

Drug Development Innovation, chaired by Barry Hardy (Douglas Connect)
Executive InnovationWell forum and roundtable discussion on Drug Development Innovation discussing the latest key advances in management practices, technology and informatics enabling the integrated advancement, success, productivity, efficacy and safety of products moving through the drug development pipeline.

Virtual Screening, Docking & Scoring, chaired by Max Cummings (Johnson & Johnson Pharmaceutical Research & Development, LLC)
Emanuele Perola (Vertex Pharmaceuticals), Mark McGann (Openeye), John Irwin (UCSF), Renee DesJarlais (Johnson & Johnson Pharmaceutical Research & Development, LLC), Willem Nissink (Cambridge Crystallographic Data Centre)

New Developments in Biophysical Applications of Quantum Mechanics, chaired by Ken Merz (University of Florida) and Lance Westerhoff (QuantumBio)
Ramkumar Rajamani (Bristol-Myers Squibb), Martin Peters (Penn State), Darrin York (University of Minnesota), Richard Friesner (Columbia University), Jiali Gao (University of Minnesota)

11 October, Afternoon

Confidence in Safety, chaired by Sidney Kahn (PvRM)
Sidney Kahn (PvRM, Inc.), A. Leander Fontaine (pharmiceutics, LLC), James Averback (Life Science Integration Partners), Peter Elkin (Mayo Clinic)

Drug Discovery Innovation, chaired by David Mosenkis
Victor Lobanov (Johnson & Johnson Pharmaceutical Research & Development, L.L.C.), Jeff Wiseman (Locus Pharmaceuticals), James H Wikel (Coalesix), G. Scott Lett (Bioanalytics Group), Randy J. Zauhar (University of the Sciences in Philadelphia)

Web-based Services in Drug Design, chaired by Marc Nicklaus (National Institutes of Health)
Brett Tounge (Johnson & Johnson Pharmaceutical Research & Development, LLC), Brad Feuston (Merck), John Irwin (UCSF), Steve Bryant (NCBI), David Covell (National Cancer Institute), Dmitrii Rassokhin (Johnson & Johnson Pharmaceutical Research & Development, LLC)

11 October, Evening - Poster Session, Networking Event & BBQ
6-10 pm local time = 18.00-22.00 EDT
(18.00 EDT == 3pm California, 6pm New York, 11pm London, midnight Zurich, 3.30am Mumbai)
Thomas Great Hall & Cloisters, Bryn Mawr College, Philadelphia, USA

12 October, Morning

Personalized Medicine: Safety and Efficacy Concerns Discussed as a Case-Study,
chaired by Donna Mendrick (Gene Logic)
Sydney Gilman (Gene Logic), Matt Cooper (Biogen Idec), Derek Janszen (Wyeth),
Steven Arnold (Queens-Long Island Medical Group), Donna Mendrick (Gene Logic),
David Teplow (David Geffen School of Medicine at UCLA)

Membranes & Ion Channels, co-chaired by Richard Pastor (FDA) and Michael Klein (University of Pennsylvania)
Mike Pitman (IBM), Jeff Klauda (NIH), Emad Tajkhorshid (Beckman Institute, University of Illinois at Urbana-Champaign), Richard Pastor (FDA), Preston Moore (USIP)

12 October, Morning and Afternoon

Knowledge Management in R&D: optimising productivity in knowledge creation,
capture, retrieval and transfer, chaired by Herschel J Weintraub (CambridgeSoft)
Peter Gates (Johnson & Johnson Pharmaceutical Research & Development, LLC), John Barrett (ITI Associates), Scott Starry (Symyx IntelliChem), Jeff Spitzner (Rescentris), James H Wikel (Coalesix), Bonnie Montano (Georgetown University), Rosemary Polsky-Newman (ExerGen Biosciences), Michael Liebman (Windber Research Institute), James M. Kanagy (GlaxoSmithKline), Rudy Potenzone (CambridgeSoft)

12 October, Afternoon

Protein Folding, Misfolding & Aggregation: Applications to Disease, chaired by Nikolay V. Dokholyan (University of North Carolina)
David Teplow (David Geffen School of Medicine at UCLA), Ron Wetzel (University of Tenessee Medical Center), Michael Thorpe (Arizona State University), Feng Ding (University of North Carolina), Andrew Miranker (Yale University), Richard Dixon (University of North Carolina)

Basel, Switzerland, 9-10 November

9 November, Morning and Afternoon

Knowledge Management in R&D: optimising productivity in knowledge creation,
capture, retrieval and transfer, chaired by Robert Scoffin (CambridgeSoft)
Alan Gibbs (Johnson & Johnson Pharmaceutical Research & Development, LLC), Kim Henrick, (European Bioinformatics Insititute), Ulrich Jordis (Vienna University of Technology), Steve Gardner (Biowisdom), Michael Swartz (CambridgeSoft), Pierre Allemand (Symyx AG), Victor Newman (The Knowledgeworks), Mark Sharp (Corpora), Rolf Jautelat (Schering AG)

9 November, Morning

Life Science Innovation Café - Confidence in Safety
A special workshop moderated by Victor Newman (Knowledgeworks) supported by expert panel

Protein Folding and Dynamics, chaired by Wilfred van Gunsteren (ETH-Zurich)
Jeremy Smith (University of Heidelberg), Wolfgang Wenzel (University of Karslruhe), Thomas Kiefhaber (University of Basel), Xavier Daura (University of Barcelona), Nikolay V. Dokholyan (University of North Carolina), Michele Vendruscolo (University of Cambridge)

9 November, Afternoon

Knowledge Management in Manufacturing: optimising efficencies in knowledge transfer
Pragmatic workshop delivered by Jim McKiernan (McKiernan Associates) and Mike Dey (Ipsen)

Confidence in Drug Safety, chaired by Jim Averback (Life Science Integration Partners)
Saad Shakir (Drug Safety Research Unit, UK), Sidney Kahn (PvRM, Inc.), A. Leander Fontaine (pharmiceutics, LLC), James Averback (Life Science Integration Partners), Peter Elkin (Mayo Clinic)

Combating Drug Counterfeiting and Trafficking, chaired by Ulrich Meier (Sun Microsystems)
Hellmuth Broda (Sun Microsystems), Dietrich Heinicke (CADAC GmbH), Saad Shakir (Drug Safety Research Unit, UK)    

Virtual Screening, Docking & Scoring, chaired by Miklos Vargyas (ChemAxon)
Graham Richards (University of Oxford), Xavier Barril (Vernalis), Amedeo Caflisch (University of Zurich), David Morley (Enspiral Discovery Ltd), Didier Rognan (University of Strasbourg)    

9 November, Evening - Poster Session, Software Demos & Networking Event
followed by group trips out in Basel for Dinner & Herbstmesse
5-8 pm local time = 17.00-20.00 CET
(17.00 CET == 8am California, 11am New York, 4pm London, 5pm Zurich, 9.30pm Mumbai [winter-time])
Swissotel L'entrée Conference Center, Basel, Switzerland

10 November, Morning

Applying Complex Systems and Organisational Development Approaches to Life Science Product Development and Drug Safety Decisions, chaired by Jim Cook (Volutio) and Barry Hardy (Douglas Connect)
David Snowden (The Cynefin Centre), Adam Filler (Denison Europe), Thomas Kell (Heidrick & Struggles), VP, Drug Development, Pharma, VP, Biotech Company, Drug Safety Expert

Drug Discovery Innovation, chaired by Alan Gibbs (Johnson & Johnson Pharmaceutical Research & Development, LLC)
Alan Gibbs (Johnson & Johnson Pharmaceutical Research & Development, LLC), Lars M. Blank (University of Dortmund and the Institute for Analytical Sciences (ISAS), Dortmund ), Michael White (School of Biological Sciences, University of Liverpool), Graham Richards (University of Oxford)

Computational Biochemistry, chaired by Alessandro Curioni (IBM Zurich)
Paul Tavan (University of Munich), Ursula Roethlisberger (Swiss Federal Institute of Technology, Lausanne), Alessandro Curioni (IBM Zurich), Ian Williams (University of Bath), Gerald Monard (Universite Henri Poincare  Nancy), Ken Merz (University of Florida and QuantumBio)

Applications of Machine Learning & Graph Mining in Drug Discovery, chaired by Stefan Kramer (Technische Universitaet Muenchen)
Christoph Helma (University of Freiburg), Peter Willett (University of Sheffield), Joost N. Kok (Leiden University), Gisbert Schneider (Johann Wolfgang Goethe-University), Michael Berthold (University of Konstanz)

10 November, Afternoon

Knowledge-based Intellectual Property Management, Auditing and Investment, chaired by Ronald Layden (Venture Valuation AG)
Rudolf Gygax (Novartis Venture Fund), Ronald Layden (Venture Valuation), Gerard Farmer (Alfomec International Regulatory Consultants), VP Business Development, Pharma, Antonino Cattaneo (Lay Line Genomics), Stefan Odenthal (Arthur D. Little)

Biosensors and Nanofluidics, chaired by Nick Quirke (Imperial College London)
Richard Gilbert (E2v Technologies), Andrew De Mello (Imperial College London), Jens Walther (ETH-Zurich), Nick Quirke (Imperial College London), Joachim Franzke (ISAS, Dortmund)

Improving Clinical Trial Effectiveness with Predictive Toxicology, Biomarkers and Pharmacogenomics, chaired by Eric Kaldjian (Gene Logic)
Christoph Helma (in silico toxicology), Eric Kaldjian (Gene Logic), Gérard Hopfgartner (University of Geneva), More TBA!

Web-based Services in Drug Design, chaired by Kim Henrick (European Bioinformatics Institute)
Dimitris Dimitropoulos (European Bioinformatics Institute), Johann Gasteiger (Universitaet Erlangen-Nuernberg), Simon Coles (University of Southampton), Eugene Krissinel (European Bioinformatics Institute), Torsten Schwede (University of Basel)